Cancer Immunotherapy Market By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy, Cytokine-based Immunotherapy, Oncolytic Virus Therapy, Others), By Cancer Type (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Blood Cancers, Others), By Route of Administration (Intravenous, Oral, Intratumoral, Subcutaneous, Others), By Biomarker Type (PD-L1 Expression, Microsatellite Instability, Tumor Mutational Burden, BRCA Mutation, HER2 Expression, Others), and By End User (Hospitals, Cancer Research Centers, Specialty Clinics, Ambulatory Surgical Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Therapy Type

• Monoclonal Antibodies
• Immune Checkpoint Inhibitors
• Cancer Vaccines
• Adoptive Cell Therapy
• Cytokine-based Immunotherapy
• Oncolytic Virus Therapy
• Others

By Cancer Type

• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Melanoma
• Blood Cancers
• Others

By Route of Administration

• Intravenous
• Oral
• Intratumoral
• Subcutaneous
• Others

By Biomarker Type

• PD-L1 Expression
• Microsatellite Instability
• Tumor Mutational Burden
• BRCA Mutation
• HER2 Expression
• Others

By End User

• Hospitals
• Cancer Research Centers
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Bristol-Myers Squibb
• Merck & Co., Inc.
• Roche Holding AG
• AstraZeneca plc
• Novartis AG
• Pfizer Inc.
• Amgen Inc.
• Johnson & Johnson
• Regeneron Pharmaceuticals, Inc.
• Gilead Sciences, Inc.
• Moderna, Inc.
• Bluebird Bio, Inc.
• Seagen Inc.
• CureVac AG
• Adaptimmune Therapeutics plc